Evidence-based supportive care in multiple myeloma.

J Community Hosp Intern Med Perspect

Department of Medicine, Division of Hematology Oncology, Blood and Marrow Transplantation, University of Arizona, Tucson, AZ, USA.

Published: August 2020

Multiple myeloma (MM) is a hematological malignancy characterized by an abnormal clone of plasma cells in the bone marrow. MM and its therapy increase the risk of complications like anemia, osteolytic lesions, pain, infections, and renal abnormalities in MM patients. Supportive care for MM patients improves the quality of life. Treatment with bisphosphonates decreases skeletal-related events. Vertebroplasty and kyphoplasty are done in cases of vertebral compression fractures. Prophylactic antibiotics and antivirals can decrease infections related to morbidity. Plasmapheresis in patients with renal dysfunctions decreases dialysis dependency and improve quality of life.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427456PMC
http://dx.doi.org/10.1080/20009666.2020.1771124DOI Listing

Publication Analysis

Top Keywords

supportive care
8
multiple myeloma
8
quality life
8
evidence-based supportive
4
care multiple
4
myeloma multiple
4
myeloma hematological
4
hematological malignancy
4
malignancy characterized
4
characterized abnormal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!